OBSERVE MEDICAL ASA: Mandatory notification of trades by primary insiders and close associate
Observe Medical ASA (OBSRV) · publisert 2026-04-09 11:40 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Glimt Invest AS nærstående | Close associate of Terje Bakken, chairperson of the board of directors of Observe Medical ASA | acquisition | 182 000 | 0 NOK | 2026-04-09 | – | XOSL – Oslo Stock Exchange / 1 NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESEPONSIBILITIES (PDMR) AND PERSONS CLOSELY ASSOCIATED WITH THEM | rules · til gjennomgang |
| Jørgen Mann | CEO | acquisition | 50 000 | 0 NOK | 2026-04-09 | – | XOSL – Oslo Stock Exchange / 1 NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESEPONSIBILITIES (PDMR) AND PERSONS CLOSELY ASSOCIATED WITH THEM | rules · til gjennomgang |
| Johan M. Fagerli | CFO | acquisition | 30 000 | 0 NOK | 2026-04-09 | – | XOSL – Oslo Stock Exchange | rules · til gjennomgang |
Vedlegg
- OMASA_PDMR_appendix_090426.pdf (tekst hentet ut)
Meldingstekst
Oslo, 9 April 2026
Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) has
been informed that Glimt Invest AS, a close associate of Terje Bakken, Chairman
of the Board and primary insider of the Company, has purchased 182,000 shares in
the Company.
Jørgen Mann, Chief Executive Officer of the Company, has purchased 50,000 shares
in the Company.
Johan Fagerli, Chief Financial Officer of the Company, has purchased 30,000
shares in the Company.
For further details, please refer to the attached notification forms.
This information is subject to the disclosure requirements pursuant to Article
19 of the EU Market Abuse Regulation and Section 5-12 of the Norwegian
Securities Trading Act.